Skip to main content
DABUR · Consumer Staples · 2026-08-28

Dabur India Ltd

Stage 4 · wk 24In scan: Breakout WatchMARKET: WEAK RECOVERING · 2026-08-28
₹386
-0.05% today
₹68,475 Cr · Large cap
About this companyConsumer Staples· FMCG - Personal Products
Expand ▾

Dabur India Limited operates as a fast moving consumer goods company worldwide. It operates through Consumer Care Business, Foods Business, Retail Business, and Other segments. The company provides health supplements under the Dabur Chyawanprash, Dabur Honey, and Dabur Glucose brand name; digestive products under the Hajmola and Pudin Hara; cough and cold products under the Honitus brands name; rejuvenators under the Shilajit brand name; health juices; nutraceuticals under the Siens brand name; and baby care products under the Dabur Lal Tail, Janma Ghunti, Gripe Water, and Dabur Baby brand names, as well as Ayurvedic Ethicals. It also offers hair care products under the Dabur Amla Hair Oil, Vatika, and Cool King brands; oral care products under the Dabur Red Toothpaste, Dabur Meswak, and Dabur Herb'l Toothpaste brand names; skin care products, including rose water, moisturising creams and lotions, soaps, body wash, toners, facial bleaches, and depilatory creams under the Dabur Gulabari and Fem & OxyLife brand names; and home care products, such as air fresheners under Odonil name, mosquito repellents under the Odomos brand, and surface cleaners under the Sanifresh brand name. In addition, the company provides beverages under the Réal and Réal Activ brand names; foods under the Dabur and Hommade brands; and spices under the Badshah brand, as well as edible oils and ghee which includes Dabur Cold Pressed Mustard Oil, Dabur Cold Pressed Sesame Oil, Dabur Cold Pressed Groundnut Oil, Dabur Virgin Coconut Oil and Dabur 100% Cow Ghee. It also operates specialized beauty retail stores that offer a range of cosmetics, fragrances, skin care, and personal care products, as well as beauty and fashion accessories under the NewU brand name. Dabur India Limited was founded in 1884 and is based in Ghaziabad, India.

Visit company website →
P/E (TTM)
41.8
Forward 33.8
Earnings Growth (YoY)
+15.2%
Revenue +7.3%
ROE
+16.2%
Profit margin +14.4%
Dividend Yield
1.84%
P/B 6.9
vs 52W High
-29.8%
₹386 lo₹549.8 hi
29.8% below 52W high — ongoing decline
In Stage 4, distance from the 52W high reflects ongoing decline — not a discount. Avoid catching falling knives.
Stage Maturity
Week 24
1w13w26w
Week 24 — extended decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure — there's no 'bottom' time to buy.
vs 200 DMA
-16.9%
200 DMA: ₹464.7 · sloping down
In Stage 4, the stock is below its 200 DMA — the hallmark of a downtrend. No long positions warranted until this reverses structurally.
Rel Volume
0.96x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low volume bounces are typical — they lack real buyers and should not be mistaken for reversals.
Trend Health
MA20 rolling over · -3.5% vs MA50 -2.5%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
Sector
Consumer Staples
↑ Building
Stage 2%
33.1%
20d Δ
+10.8pp
1M return
-2.6%
3M return
+1.6%
Sector Stage-2 % · last 20 days
Sector has 56 Stage 2 leaders. See Consumer Staples Stage 2 →
Industry
FMCG - Personal Products
↓ Peaking
Stage 2%
27.3%
20d Δ
-9.1pp
1M return
-6.2%
3M return
+5.6%
Industry Stage-2 % · last 20 days
Industry has 3 Stage 2 leaders. See FMCG - Personal Products Stage 2 →
Price + Volume Chart
Loading price chart…
Stage Cycle Timeline2023-06-05 → 2026-08-28
S2 17w
S4 16w
S4 23w
2023-06-052026-08-28
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 5w → S2 9w → S3 8w → S4 8w → S1 9w → S4 11w → S1 2w → S2 17w → S3 7w → S4 11w → S1 4w → S4 16w → S1 5w → S2 8w → S3 12w → S2 10w → S3 1w → S4 23w current
Total tracked: 167 weeks across 18 stage runs.
1M
-9.4%
3M
-9.1%
6M
-25.0%
YTD
-21.7%
1Y
-24.8%
Scan Membership
Breakout Watch
Latest: 2026-01-07
3 appearances in last 60 days. First seen: 2024-06-13.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-08-28S4
Wk 24 · Vol x
2026-08-27S4
Wk 23 · Vol x
2026-08-26S4
Wk 23 · Vol x
2026-08-25S4
Wk 23 · Vol x
2026-08-24S4
Wk 23 · Vol x
2026-08-21S4
Wk 22 · Vol x
2026-08-20S4
Wk 22 · Vol x
2026-08-19S4
Wk 22 · Vol x
2026-08-18S4
Wk 21 · Vol x
2026-08-17S4
Wk 21 · Vol x
2026-08-14S4
Wk 21 · Vol x
2026-08-13S4
Wk 21 · Vol x
Sector Peers — Stage 2All →
AVADHSUGAR
wk 19 · -0.6% from hi
10.0
MAWANASUG
wk 18 · -3.0% from hi
9.4
TI
wk 3 · -2.7% from hi
9.2
PONNIERODE
wk 16 · -5.9% from hi
8.9
MANORAMA
wk 14 · -3.5% from hi
8.9
Moving averages & range
50 DMA
₹420.7
200 DMA
₹464.7
52W High
₹549.8
52W Low
₹386
5D Low
₹386
Resistance levels (recent highs)
20d High
₹425.8
60d High
₹453.5
120d High
₹487.9
250d High
₹549.8
Next resistance
+10.3%
to 20d High

All analytics based on EOD data. Data as of 2026-08-28. Past data patterns are not indicative of future results. This page is a data analytics tool only.